High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 11-12, 2009, Pages 4623-4635

  Petoumenos, Vasileios ^a   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Endothelial progenitor cells; Endothelium; High density lipoprotein

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; NOS3 PROTEIN, HUMAN; PROTECTIVE AGENT; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BLOOD VESSEL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MONONUCLEAR CELL; MOUSE; STEM CELL;

ANIMALS; APOPTOSIS; BLOOD VESSELS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, HDL; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTECTIVE AGENTS; RECOMBINANT PROTEINS; RNA, MESSENGER; STEM CELLS;

MUS;

EID: 66949135110     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00472.x     Document Type: Article

References (50)

1. Shi Q, Rafii S, Wu MH. Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998, 92:362-7.
2. Walter DH, Rittig K, Bahlmann FH. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002, 105:3017-24.
3. Wassmann S, Werner N, Czech T. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res. 2006, 99:e74-83.
4. Werner N, Priller J, Laufs U. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002, 22:1567-72.
5. Werner N, Junk S, Laufs U. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003, 93:e17-24.
6. Crosby JR, Kaminski WE, Schatteman G. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res. 2000, 87:728-30.
7. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis. J Mol Med. 2004, 82:671-7.
8. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med. 2006, 10:318-32.
9. Imanishi T, Hano T, Sawamura T. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol. 2004, 31:407-13.
10. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 2003, 108:457-63.
11. Tepper OM, Galiano RD, Capla JM. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002, 106:2781-6.
12. Vasa M, Fichtlscherer S, Aicher A. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001, 89:E1-7.
13. Heeschen C, Lehmann R, Honold J. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischaemic heart disease. Circulation. 2004, 109:1615-22.
14. Dimmeler S, Aicher A, Vasa M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001, 108:391-7.
15. Laufs U, Werner N, Link A. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation. 2004, 109:220-6.
16. Laufs U, Wassmann S, Czech T. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005, 25:809-14.
17. Strehlow K, Werner N, Berweiler J. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 2003, 107:3059-65.
18. Schmidt-Lucke C, Rossig L, Fichtlscherer S. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005, 111:2981-7.
19. Werner N, Kosiol S, Schiegl T. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005, 353:999-1007.
20. Barter P, Gotto AM, LaRosa JC. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007, 357:1301-10.
21. Spieker LE, Sudano I, Hurlimann D. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 2002, 105:1399-1402.
22. Buring JE, O'Connor GT, Goldhaber SZ. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation. 1992, 85:22-9.
23. Thompson MM, Reed SC, Cockerill GW. Therapeutic approaches to raising plasma HDL-cholesterol levels. Nat Clin Pract Cardiovasc Med. 2004, 1:84-9.
24. Tso C, Martinic G, Fan WH. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol. 2006, 26:1144-9.
25. Noor R, Shuaib U, Wang CX. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis. 2007, 192:92-9.
26. Sumi M, Sata M, Miura S. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007, 27:813-8.
27. van Oostrom O, Nieuwdorp M, Westerweel PE. Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2007, 27:1864-5.
28. Tardif JC, Gregoire J, L'Allier PL. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA. 2007, 297:1675-82.
29. Kastelein JJ, van Leuven SI, Burgess L. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007, 356:1620-30.
30. Nissen SE, Tardif JC, Nicholls SJ. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007, 356:1304-16.
31. Redgrave TG, Roberts DC, West CE. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975, 65:42-9.
32. Wassmann S, Wassmann K, Jung A. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol. 2007, 43:301-7.
33. Fontaine V, Filipe C, Werner N. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. Am J Pathol. 2006, 169:1855-62.
34. Duda DG, Cohen KS, Scadden DT. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007, 2:805-10.
35. Wu Y, Ip JE, Huang J. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006, 99:315-22.
36. Voermans C, Rood PM, Hordijk PL. Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells. Stem Cells. 2000, 18:435-43.
37. Chavakis E, Aicher A, Heeschen C. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med. 2005, 201:63-72.
38. Duan H, Cheng L, Sun X. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Thromb Haemost. 2006, 96:807-15.
39. Qin G, Ii M, Silver M. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med. 2006, 203:153-63.
40. Ip JE, Wu Y, Huang J. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007, 18:2873-82.
41. Smadja DM, Bieche I, Helley D. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). J Cell Mol Med. 2007, 11:1149-61.
42. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood. 2005, 106:1525-31.
43. Dernbach E, Urbich C, Brandes RP. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood. 2004, 104:3591-7.
44. Seetharam D, Mineo C, Gormley AK. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res. 2006, 98:63-72.
45. Harraz M, Jiao C, Hanlon HD. CD34 negative blood-derived human endothelial cell progenitors. Stem Cells. 2001, 19:304-12.
46. Hur J, Yoon CH, Kim HS. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004, 24:288-93.
47. Iwakura A, Luedemann C, Shastry S. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003, 108:3115-21.
48. Sandri M, Adams V, Gielen S. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation. 2005, 111:3391-9.
49. Eichinger S, Pecheniuk NM, Hron G. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation. 2007, 115:1609-14.
50. Smadja DM, Basire A, Amelot A. Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J Cell Mol Med. 2008, 12:975-86.